UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

The New England journal of medicine, 2016-11, Vol.375 (18), p.1749-1755

2016

Volltextzugriff (PDF)

Muscle-specific stress fibers give rise to sarcomeres in cardiomyocytes

eLife, 2018-12, Vol.7

2018

Volltextzugriff (PDF)

Replication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling

Journal of the American Heart Association, 2021-08, Vol.10 (15), p.e021768-e021768

2021

Volltextzugriff (PDF)

Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development

Development (Cambridge), 2014-01, Vol.141 (2), p.335-345

2014

Volltextzugriff (PDF)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity

Open heart, 2021-02, Vol.8 (1), p.e001560

2021

Volltextzugriff (PDF)

Response by Shridhar et al to Letter Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy"

Circulation (New York, N.Y.), 2024-08, Vol.150 (9), p.e201

2024

Volltextzugriff (PDF)

Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies

Cardiovascular research, 2019-04, Vol.115 (5), p.966-977

2019

Volltextzugriff (PDF)

MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy

Circulation (New York, N.Y.), 2023-12, Vol.148 (23), p.1870-1886

2023

Volltextzugriff (PDF)

Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling

Cardiovascular research, 2022-07, Vol.118 (9), p.2124-2138

2022

Volltextzugriff (PDF)

Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development

JCI insight, 2017-02, Vol.2 (4), p.e90656-e90656

2017

Volltextzugriff (PDF)

A Comparative Study of Single-pulse and Double-pulse Laser-Induced Breakdown Spectroscopy with Uranium-containing Samples

Applied spectroscopy, 2016-03, Vol.70 (3), p.467-473

2016

Volltextzugriff (PDF)

Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

Circulation. Heart failure, 2024-08, Vol.17 (8), p.e011663

2024

Volltextzugriff (PDF)

Nuclear localized Raf1 isoform alters DNA‐dependent protein kinase activity and the DNA damage response

The FASEB journal, 2019-01, Vol.33 (1), p.1138-1150

2019

Volltextzugriff (PDF)

In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling

Cardiovascular research, 2012-03, Vol.93 (3), p.463-470

2012

Volltextzugriff (PDF)

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Circulation. Heart failure, 2023-04, Vol.16 (4), p.e010314-e010314

2023

Volltextzugriff (PDF)

Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy

Circulation. Cardiovascular genetics, 2013-08, Vol.6 (4), p.317-326

2013

Volltextzugriff (PDF)

MULTIPARITY ADVERSELY IMPACTS MYOCARDIAL REMODELING IN A MURINE SARCOMERIC CARDIOMYOPATHY MODEL

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.844-844

2021

Volltextzugriff (PDF)

Abstract 198: Familial Hypercholesterolemia and Intra-Cranial Aneurysm: A Novel Phenotypic and Genetic Association

Arteriosclerosis, thrombosis, and vascular biology, 2015-05, Vol.35 (suppl_1)

2015

Volltextzugriff (PDF)

Abstract 12135: Quality of Life in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Abstract 738: Comparative Cardiotoxicity of Tyrosine Kinase Inhibitors Ponatinib and PF114

Circulation research, 2019-08, Vol.125 (Suppl_1)

2019

Volltextzugriff (PDF)

Abstract 361: Analysis of Cardiotoxic Mechanisms Associated With Tyrosine Kinase Inhibitor Ponatinib

Circulation research, 2018-08, Vol.123 (Suppl_1)

2018

Volltextzugriff (PDF)

Abstract 901: Muscle-specific Stress Fibers Give Rise to Sarcomeres in Cardiomyocytes

Circulation research, 2019-08, Vol.125 (Suppl_1)

2019

Volltextzugriff (PDF)

Abstract 20006: RNA Sequencing of Human Hypertrophic Cardiomyopathy Tissue Reveals Diverse Pathways Modulating the Myocardial Tissue Microenvironment

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Englisch
(236)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(16)
Circulation
(7)
Plos One
(5)
The Astronomical Journal
(5)
Cell Reports
(4)
Circulation. Heart Failure
(4)
Jci Insight
(4)
Kansas Agricultural Experiment Station Research Reports
(4)
Leukemia
(4)
Otolaryngology-Head And Neck Surgery
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Muscle-specific stress fibers give rise to sarcomeres in cardiomyocytes

Replication Stress Response Modifies Sarcomeric Cardiomyopathy Remodeling

Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during development

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity

Response by Shridhar et al to Letter Regarding Article, "MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy"

Ponatinib-induced cardiotoxicity: delineating the signalling mechanisms and potential rescue strategies

MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy

Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial

Cardiac natriuretic peptide deficiency sensitizes the heart to stress-induced ventricular arrhythmias via impaired CREB signalling

Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development

A Comparative Study of Single-pulse and Double-pulse Laser-Induced Breakdown Spectroscopy with Uranium-containing Samples

Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

Nuclear localized Raf1 isoform alters DNA‐dependent protein kinase activity and the DNA damage response

In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling

Transforming Growth Factor-β Analysis of the VANISH Trial Cohort

Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy

Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial

MULTIPARITY ADVERSELY IMPACTS MYOCARDIAL REMODELING IN A MURINE SARCOMERIC CARDIOMYOPATHY MODEL

Abstract 198: Familial Hypercholesterolemia and Intra-Cranial Aneurysm: A Novel Phenotypic and Genetic Association

Abstract 12135: Quality of Life in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial

Abstract 738: Comparative Cardiotoxicity of Tyrosine Kinase Inhibitors Ponatinib and PF114

Abstract 361: Analysis of Cardiotoxic Mechanisms Associated With Tyrosine Kinase Inhibitor Ponatinib

Abstract 901: Muscle-specific Stress Fibers Give Rise to Sarcomeres in Cardiomyocytes

Abstract 20006: RNA Sequencing of Human Hypertrophic Cardiomyopathy Tissue Reveals Diverse Pathways Modulating the Myocardial Tissue Microenvironment

Suchergebnisse filtern